CubeX-OTC Newsline Issue No. XIX (www.cubex.co.in ) INDIA HIGHLIGHTS MEGATRENDS TO RESHAPE INDIA Urbanization – rise in the number of mega cities, growing working population in the age group of 15‐64 years and the increasing usage of smart phones are all "megatrends" that will reshape India in the next decade. Anand Rangachary of Frost & Sullivan, said: "As India is on the threshold of emerging as the world's second‐fastest growing economy, megatrends can help companies harness this potential to be more proactive and innovative in their growth strategies.” Broader possibilities are presented by the healthcare sector, anticipated to be worth $276bn in 2020, versus $50bn in 2011, aided by "medical tourism" and the roll out of digital platforms. (http://www.warc.com/Content/News/Megatrends_to_reshape_India.content?ID=b50a65c1‐4560‐ 4137‐ad0d‐e032fbcdd2c5 ) Comment: Mega trends will give way to sizeable opportunities for various companies across different industries and pharma industry is no different. Digitalization has been accepted widely with the use of Facebook and QR codes. Also, the launch of innovative health apps, which help one to check their blood pressure, blood sugar levels and report fluctuations to their doctors in real time for immediate action, will steadily become popular. These moves are an example of how emerging markets like India are increasingly becoming a part of the “connected world”. AVESTHAGEN FLOATS JV WITH SAVA MEDICA TO SELL NUTRACEUTICALS Biotech major Avesthagen has partnered with Sava Medica Ltd of Pune to float 50:50 joint venture subsidiary — Dhanvantari Botanicals — to market a range of nutraceuticals products in the US and BRIS (Brazil, Russia, India and South Africa) countries. Through this joint venture, Avesthagen grants and Sava Medica earns marketing rights for Avesthagen's seven over‐the‐counter (OTC) tablet (including child‐ convenient dose such as fast‐dissolving tablet), capsule and liquid formulations. Dhanvantari Botanical's product basket includes 11 OTC brands positioned for the wellness and nutraceutical markets. They are AmlaPure, Ashwagandha, BosWell, Gymnema, ThinkWell, Tribulus, Triphala, TriplaLax, WinterWell, XanoMax and GojiMax and a few qualified bulk ingredients. (http://www.thehindubusinessline.com/companies/article2585643.ece ) Comment: VMS market is as big as US$ 680.30 mn and recorded a growth rate of 8.35%. Nutraceuticals is the buzz word in the pharma market today. This category is niche but has been observing a lot of attention in the recent past. As covered in previous issues of Cubex‐OTC Newsline , India has seen a lot of new launches in this space. This slew of new launches, mainly through JVs of foreign and Indian
4
Embed
CubeX-OTC Newsline Issue No. XIX ()cubex.co.in/issue pdf/otc newsline issue no.xix.pdfCubeX-OTC Newsline Issue No. XIX () INDIA HIGHLIGHTS MEGATRENDS TO RESHAPE INDIA Urbanization
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
CubeX-OTC Newsline Issue No. XIX (www.cubex.co.in)
INDIA HIGHLIGHTS
MEGATRENDS TO RESHAPE INDIA
Urbanization – rise in the number of mega cities, growing working population in the age group of 15‐64
years and the increasing usage of smart phones are all "megatrends" that will reshape India in the next
decade. Anand Rangachary of Frost & Sullivan, said: "As India is on the threshold of emerging as the
world's second‐fastest growing economy, megatrends can help companies harness this potential to be
more proactive and innovative in their growth strategies.” Broader possibilities are presented by the
healthcare sector, anticipated to be worth $276bn in 2020, versus $50bn in 2011, aided by "medical